Unlock instant, AI-driven research and patent intelligence for your innovation.
Diarylamide compound and application thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A compound, formamide technology, applied in the field of diuretics, can solve the problem of no increase in urine osmotic pressure
Active Publication Date: 2020-12-22
SUNSHINE LAKE PHARM CO LTD
View PDF5 Cites 1 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
And after 5 days of strictly controlled fluid intake, their urine osmolality did not increase
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0219] Example 1 N-(4-acetylaminophenyl)-4-nitrobenzamide
[0220]
[0221] Suspend p-nitrobenzoic acid (3-1a, 167mg, 1mmol) in dichloromethane (5mL), add 2 drops of DMF, and cool to 0°C in an ice-water bath. Oxalyl chloride (190mg, 0.13mL, 1.5mmol) was slowly added dropwise, and the mixture was stirred at room temperature for 2 hours. The reaction solution was concentrated to remove the solvent and excess oxalyl chloride to obtain p-nitrobenzoyl chloride (3-2a), which was added to tetrahydrofuran (1 mL) for later use without further purification. Paracetaminoaniline (3-3a, 150 mg, 1 mmol) was dissolved in tetrahydrofuran (5 mL), triethylamine (152 mg, 1.5 mmol) was added, and the tetrahydrofuran solution of the above acid chloride 3-2a was added dropwise under ice bath. After dropping, react at room temperature to TLC (CH 2 Cl 2 :MeOH=15:1) showed that the reaction was complete. Add 30 mL of water to the reaction system, continue to stir for 10 minutes and then filter ...
[0229] Synthetic method is the same as embodiment 1. Orange solid, yield 80%, melting point 233-234°C.
[0230] 1 H NMR (400MHz, DMSO-d 6 )δ10.59(s,1H),9.97(s,1H),7.81(d,J=4.0Hz,1H),7.62-7.66(m,3H),7.57(d,J=8.8Hz,2H), 2.04(s,3H); 13 C NMR (101MHz, DMSO-d 6 )δ168.61, 154.79, 152.20, 148.56, 136.49, 133.32, 121.66, 119.71, 116.77, 113.97, 24.40. HRMS m / z: calcd for C 16 h 13 N 3 o 4 ,([M+H]+):285.08698,Found:285.08696.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Property
Measurement
Unit
Melting point
aaaaa
aaaaa
Melting point
aaaaa
aaaaa
Melting point
aaaaa
aaaaa
Login to View More
Abstract
The invention discloses a use of a diarylamide compound with a structure shown as a formula (I), and a pharmaceutically acceptable salt thereof in the preparation of a medicine serving as a ureatransporter inhibitor, and the novel diarylamide compound. The diarylamide compound has good ureatransporter inhibitor effects, can generate urea selective diuresisin vivo, and has no obvious toxic effects.
Description
technical field [0001] The invention relates to the field of diuretics, in particular to diarylamide compounds, their pharmaceutically acceptable salts and their use in the preparation of drugs as urea channel protein inhibitors. Background technique [0002] 1. Current applications and research and development hotspots of diuretics [0003] Diuretics act on the kidneys to increase water excretion. Clinically, it is mainly used to treat edema caused by various reasons, and it can also be used to treat some non-edematous diseases. For example, as a first-line drug, it can be used alone or in combination with other drugs to treat hypertension, reduce the incidence of cardiovascular and cerebrovascular diseases and mortality Rate. Diuretics can be divided into potassium-sparing diuretics, thiazide diuretics, loop diuretics, and carbonic anhydrase inhibitors according to their different sites of action. Potassium-sparing diuretics represented by amiloride and triamterene main...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.